| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.619 | 23.533 | 32.887 | 43.695 | 23.638 | 19.205 | 37.951 | 17.283 | - |
| Total Income - EUR | - | 6.619 | 23.533 | 32.977 | 43.938 | 23.640 | 19.205 | 38.119 | 17.283 | - |
| Total Expenses - EUR | - | 1.247 | 2.946 | 7.561 | 11.088 | 14.511 | 3.193 | 14.214 | 13.110 | - |
| Gross Profit/Loss - EUR | - | 5.372 | 20.587 | 25.416 | 32.849 | 9.129 | 16.011 | 23.904 | 4.173 | - |
| Net Profit/Loss - EUR | - | 5.173 | 19.881 | 24.419 | 31.531 | 8.427 | 15.447 | 22.761 | 4.000 | - |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - |
Check the financial reports for the company - Endometabolic Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 1.665 | 1.056 | 471 | 0 | 0 | 0 | - |
| Current Assets | - | 5.448 | 25.372 | 48.513 | 78.612 | 77.923 | 88.882 | 101.487 | 122.972 | - |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.615 | - |
| Receivables | - | 0 | 1.620 | 10.178 | 27.296 | 16.885 | 29.300 | 31.297 | 26.614 | - |
| Cash | - | 5.448 | 23.751 | 38.335 | 51.316 | 61.037 | 59.581 | 70.189 | 87.743 | - |
| Shareholders Funds | - | 5.218 | 25.011 | 48.970 | 76.891 | 74.946 | 83.410 | 94.477 | 98.191 | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | 230 | 361 | 1.207 | 2.777 | 3.448 | 5.471 | 7.009 | 24.781 | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Endometabolic Research Srl